In a direct-to-patient move likely to reverberate across the pharmaceutical landscape, Bristol-Myers Squibb and Pfizer announced today they will begin offering their blockbuster blood thinner Eliquis ...
The 2022 Inflation Reduction Act (IRA) contains multiple provisions related to high-cost branded prescription drugs used by Medicare beneficiaries. One provision, effective in 2025, will cap Part D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback